Highly Reactive Sequences For PLP-Mediated Bioconjugation
A R T I C L E S
cysteine alkylation12 as well as C-terminal modification using
native chemical ligation (NCL).19,20
PLP-mediated bioconjugation has been used to modify a
number of different proteins in applications ranging from surface
and polymer attachment21 to the dual modification of viral coat
proteins with different chromophores for light harvesting
systems.12 Since the initial report of this method for protein
functionalization, our group has sought to explore the scope of
this reaction and to improve its reliability for new protein targets.
Our previous work has shown that the transamination reactivity
of a protein is dependent on the identity of the N-terminal
residue, as well as those in the second and third positions.9 The
terminal and internal residues were found to have a complex
synergistic effect on the overall reactivity, quickly outpacing
our ability to screen sequence candidates individually.
Based on the observation that the penultimate and antepen-
ultimate residues are significant in determining the reactivity
of peptides and proteins toward PLP-mediated N-terminal
transamination, we sought to identify the most highly reactive
sequences of amino acids from the chemical space spanning
all combinations of three N-terminal residues. To identify such
sequences, we developed a combinatorial peptide library screen-
ing platform based on a colorimetric detection of desired
reactivity, as outlined in Figure 2. Using stringent reaction
conditions to screen for the most active sequences, a highly
conserved alanine-lysine motif was identified. The improved
reactivity of this motif was verified on peptide substrates, and
the scope was explored using positional scanning experiments.
Additionally, we introduced this sequence on two proteins using
site-directed mutagenesis. In both cases, the alanine-lysine
mutants exhibited improved yields relative to the wild-type
termini. It is anticipated that this new, highly reactive motif
will serve to increase the reactivity of many other protein targets.
Figure 1. The general scheme of PLP-mediated bioconjugation. (a) In the
first step, a protein is incubated with PLP (1) under mild, aqueous conditions.
This oxidizes the N-terminus of the protein to a ketone or an aldehyde,
providing a unique functional group for further modification. (b) In the
second step, the ketone is conjugated to an alkoxyamine-bearing reagent
(2) through oxime formation. (c) The proposed mechanism begins with
Schiff base formation between the N-terminal amine and the PLP aldehyde.
Tautomerization, followed by hydrolysis, affords the keto-protein product.
specificity by targeting the N-terminus, a unique position in the
sequence. When incubated with pyridoxal 5′-phosphate (PLP),
the N-terminal amine undergoes a transamination reaction that
installs a ketone or an aldehyde in that position without
modifying lysine side chain amines.7 The unique reactivity of
the new carbonyl group relative to native side chain function-
alities allows for further conjugation to alkoxyamine-containing
probes via oxime formation10,11 (Figure 1). This technique
provides a convenient and readily scalable way to install a single
functional group in a single location and has been shown to
tolerate free cysteine residues.4,5,12
Results and Discussion
Design of a Peptide Library Screening Platform. Although
the reactivity of full-sized proteins will undoubtedly be influ-
enced by their tertiary structure, previous work9 had demon-
strated that general trends in N-terminal reactivity were con-
sistent between peptide and protein substrates. This observation
suggested that it would be possible to screen peptide libraries
to identify sequences that would retain their reactivity in the
protein context. To do this, we developed a screening platform
by adapting a number of traditional techniques used for the
construction of solid-phase combinatorial peptide libraries.22 As
our objective was to find a short genetically encodable sequence
that could be conveniently introduced through mutagenesis, we
limited our randomization to the terminal three residues, which
were followed by an invariant region that could include
purification handles or other sequences of interest in future
There are other methods of N-terminal modification,13-17
each of which may be suitable for different applications and
proteins. N-terminal tryptophan residues16 can be ligated to
aldehyde reagents via a Pictet-Spengler reaction, but it can be
difficult to obtain proteins with a tryptophan in the N-terminal
position.18 N-terminal serines and threonines can be cleaved
using sodium periodate to yield aldehyde functionalities for
further derivitization.17 However, sodium periodate may not be
compatible with some applications, such as glycoproteins and
proteins with large numbers of cysteine or methioine residues.5
PLP-mediated transamination is complementary to these other
methods of N-terminal modification and is especially useful
because of its compatibility with other protein modification
strategies. For instance, it can be used in combination with
(19) (a) Dawson, P. E.; Muir, T. W.; Clarklewis, I.; Kent, S. B. H. Science
1994, 266, 776–779. (b) Hofmann, R. M.; Muir, T. W. Curr. Opin.
Biotechnol. 2002, 13, 297–303. (c) Tolbert, T. J.; Wong, C. H. J. Am.
Chem. Soc. 2000, 122, 5421–5428.
(10) Jencks, W. P. J. Am. Chem. Soc. 1959, 81, 475–481.
(11) Rose, K. J. Am. Chem. Soc. 1994, 116, 30–33.
(12) Dedeo, M. T.; Duderstadt, K. E.; Berger, J. M.; Francis, M. B. Nano
Lett. 2010, 10, 181–186.
(20) Esser-Kahn, A. P.; Francis, M. Angew. Chem., Int. Ed. 2008, 120,
3811–3814.
(13) Tam, J. P.; Yu, Q.; Miao, Z. Biopolymers 1999, 51, 311–332.
(14) Dixon, H. B. F. J. Protein Chem. 1984, 3, 99–108.
(15) Dixon, H. B. F.; Fields, R. Methods Enzymol. 1972, 25, 409–419.
(16) Li, X.; Zhang, L.; Hall, S. E.; Tam, J. P. Tetrahedron Lett. 2000, 41,
4069–4073.
(21) (a) Christman, K. L.; Broyer, R. M.; Tolstyka, Z. P.; Maynard, H. D.
J. Mater. Chem. 2007, 17, 2021–2027. (b) Lempens, E. H. M.; Helms,
B. A.; Merkx, M.; Meijer, E. W. ChemBioChem 2009, 10, 658–662.
(c) Gao, W.; Liu, W.; Mackay, J. A.; Zalutsky, M. R.; Toone, E. J.;
Chilkoti, A. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 15231–15236.
(22) (a) Lam, K.; Lebl, M.; Krchnak, V. Chem. ReV. 1997, 97, 411–448.
(b) Lam, K. S.; Salmon, S. E.; Hersh, E. M.; Hruby, V. J.; Kazmierski,
W. M.; Knapp, R. J. Nature 1991, 354, 82–84.
(17) Geoghegan, K. F.; Stroh, J. G. Bioconjugate Chem. 1992, 3, 138–
146.
(18) Hirel, P. H.; Schmitter, M. J.; Dessen, P.; Fayat, G.; Blanquet, S. Proc.
Natl. Acad. Sci. U.S.A. 1989, 86, 8247–8251.
9
J. AM. CHEM. SOC. VOL. 132, NO. 47, 2010 16813